Brian S. Decker

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for <i>CYP3A5</i> Genotype and Tacrolimus Dosing

Brian S. Decker, JM Barbarino, JF Peterson et al. · Clinical Pharmacology & Therapeutics · 2015 · 692 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

Gary R. Matzke, George R. Aronoff, Arthur J. Atkinson et al. · Kidney International · 2011 · 455 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

The EXTRIP (<i>EXtracorporeal TReatments In Poisoning</i>) workgroup: Guideline methodology

Valéry Lavergne, Thomas D. Nolin, Robert S. Hoffman et al. · Clinical Toxicology · 2012 · 134 citations · Full text

Medicine, Clinical Toxicology, Nephrology +16

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

Kelly A. Birdwell, Brian S. Decker, Julia M. Barbarino et al. · Data Archiving and Networked Services (DANS) · 2015 · 88 citations

Medicine, Pharmacokinetics, Pharmacology +16

Targeting the hepcidin–ferroportin pathway in anaemia of chronic kidney disease

Matthew J. Sheetz, Philip Barrington, Sophie Callies et al. · British Journal of Clinical Pharmacology · 2019 · 75 citations · Full text

Medicine, Molecular Medicine, Nephrology +17